Renal cell carcinoma articles within Scientific Reports

Featured

• Article
  23 April 2024 | Open Access

  Integrating tumor and healthy epithelium in a micro-physiology multi-compartment approach to study renal cell carcinoma pathophysiology

  • Maryna Somova
  • , Stefan Simm
  •  & Pedro Caetano Pinto

• Article
  13 April 2024 | Open Access

  Circulating microRNA-155-3p levels predicts response to first line immunotherapy in patients with metastatic renal cell carcinoma

  • Maryam Soleimani
  • , Marisa Thi
  •  & Lucia Nappi

• Article
  23 February 2024 | Open Access

  Risk factors of recurrence after robot-assisted laparoscopic partial nephrectomy for solitary localized renal cell carcinoma

  • Jae Hoon Chung
  • , Wan Song
  •  & Seong IL Seo

• Article
  17 January 2024 | Open Access

  Immunomodulatory response to neoadjuvant nivolumab in non-metastatic clear cell renal cell carcinoma

  • Nirmish Singla
  • , Thomas R. Nirschl
  •  & Charles G. Drake

• Article
  05 January 2024 | Open Access

  Development of a novel disulfidptosis-related lncRNA signature for prognostic and immune response prediction in clear cell renal cell carcinoma

  • Ning Wang
  • , Yifeng Hu
  •  & Fengmin Shao

• Article
  20 November 2023 | Open Access

  Leveraging diverse cell-death patterns to predict the prognosis, immunotherapy and drug sensitivity of clear cell renal cell carcinoma

  • Xi Zhang
  • , Mingcong Zhang
  •  & Ninghong Song

• Article
  13 September 2023 | Open Access

  Identification of microRNA editing sites in clear cell renal cell carcinoma

  • Yulong Liu
  • , Shiyong Guo
  •  & Yun Zheng

• Article
  03 August 2023 | Open Access

  A pilot radiometabolomics integration study for the characterization of renal oncocytic neoplasia

  • Michail E. Klontzas
  • , Emmanouil Koltsakis
  •  & Antonios Tzortzakakis

• Article
  07 July 2023 | Open Access

  Recurrence prediction in clear cell renal cell carcinoma using machine learning of quantitative nuclear features

  • Shuya Matsubara
  • , Akira Saito
  •  & Yoshio Ohno

• Article
  29 June 2023 | Open Access

  Cancer associated macrophage-like cells in metastatic renal cell carcinoma predicts for poor prognosis and tracks treatment response in real time

  • Amama Ali
  • , Daniel L. Adams
  •  & Thai H. Ho

• Article
  16 June 2023 | Open Access

  Integrative transcriptome and proteome analyses of clear cell renal cell carcinoma develop a prognostic classifier associated with thrombus

  • Xiaolei Shi
  • , Qingyang Pang
  •  & Wei Zhang

• Article
  31 October 2022 | Open Access

  Positive surgical margin’s impact on short-term oncological prognosis after robot-assisted partial nephrectomy (MARGINS study: UroCCR no 96)

  • Arnoult Morrone
  • , Imad Bentellis
  •  & Matthieu Durand

• Article
  26 August 2022 | Open Access

  Identification of key genes of the ccRCC subtype with poor prognosis

  • Grigory Andreevich Puzanov

• Article
  05 August 2022 | Open Access

  A multiomics disease progression signature of low-risk ccRCC

  • Philipp Strauss
  • , Mariell Rivedal
  •  & Hans-Peter Marti

• Article
  17 June 2022 | Open Access

  Active surveillance versus initial surgery in the long-term management of Bosniak IIF–IV cystic renal masses

  • Lassi Luomala
  • , Juhana Rautiola
  •  & Harry Nisén

• Article
  20 April 2022 | Open Access

  Evaluation of a seven gene mutational profile as a prognostic factor in a population-based study of clear cell renal cell carcinoma

  • Jeroen A. A. van de Pol
  • , Paranita Ferronika
  •  & Klaas Kok

• Article
  01 October 2021 | Open Access

  Time-gated Raman spectroscopy and proteomics analyses of hypoxic and normoxic renal carcinoma extracellular vesicles

  • Anatoliy Samoylenko
  • , Martin Kögler
  •  & Jussi Hiltunen

• Article
  21 July 2021 | Open Access

  VHL suppresses RAPTOR and inhibits mTORC1 signaling in clear cell renal cell carcinoma

  • Athina Ganner
  • , Christina Gehrke
  •  & Elke Neumann-Haefelin

• Article
  04 June 2021 | Open Access

  Kidney injury molecule-1 inhibits metastasis of renal cell carcinoma

  • Jasper C. Lee
  • , Demitra M. Yotis
  •  & Lakshman Gunaratnam

• Article
  13 May 2021 | Open Access

  Repurposing ketoconazole as an exosome directed adjunct to sunitinib in treating renal cell carcinoma

  • Jacob W. Greenberg
  • , Hogyoung Kim
  •  & Louis S. Krane

• Article
  25 February 2021 | Open Access

  A convention-radiomics CT nomogram for differentiating fat-poor angiomyolipoma from clear cell renal cell carcinoma

  • Yanqing Ma
  • , Weijun Ma
  •  & Peipei Pang

• Article
  22 February 2021 | Open Access

  Immune classification of clear cell renal cell carcinoma

  • Sumeyye Su
  • , Shaya Akbarinejad
  •  & Leili Shahriyari

• Article
  18 November 2020 | Open Access

  First-line axitinib therapy is less effective in metastatic renal cell carcinoma with spindle histology

  • Kazuyuki Numakura
  • , Mizuki Kobayashi
  •  & Tomonori Habuchi

• Article
  29 October 2020 | Open Access

  HIFα independent mechanisms in renal carcinoma cells modulate divergent outcomes in fibronectin assembly mediated by hypoxia and CoCl₂

  • Carina Magdaleno
  • , Leah Dixon
  •  & Archana Varadaraj

• Article
  01 October 2020 | Open Access

  The suitability of NONO-TFE3 dual-fusion FISH assay as a diagnostic tool for NONO-TFE3 renal cell carcinoma

  • Ning Liu
  • , Wei Guo
  •  & Dongmei Li

• Article
  22 July 2020 | Open Access

  Label-free detection of rare circulating tumor cells by image analysis and machine learning

  • Shen Wang
  • , Yuyuan Zhou
  •  & Yaling Liu

• Article
  10 April 2020 | Open Access

  Tumour grade significantly correlates with total dysfunction of tumour tissue-infiltrating lymphocytes in renal cell carcinoma

  • Atsunari Kawashima
  • , Takayuki Kanazawa
  •  & Norio Nonomura

• Article
  10 February 2020 | Open Access

  Comparative Clinicopathologic Characteristics and Outcomes of Paediatric and Adult Xp11 Translocation Renal Cell Carcinomas: a Retrospective Multicentre Study in China

  • Wenliang Ma
  • , Ning Liu
  •  & Weidong Gan

• Article
  06 February 2020 | Open Access

  Identification of gene signature for treatment response to guide precision oncology in clear-cell renal cell carcinoma

  • Ninadh M. D’Costa
  • , Davide Cina
  •  & Alan I. So

• Article
  10 January 2020 | Open Access

  Germline polymorphisms in the Von Hippel-Lindau and Hypoxia-inducible factor 1-alpha genes, gene-environment and gene-gene interactions and renal cell cancer

  • Jeroen A. A. van de Pol
  • , Piet A. van den Brandt
  •  & Leo J. Schouten

• Article
  27 December 2019 | Open Access

  Reduction in the Incidence of Urological Cancers after the Ban on Chinese Herbal Products Containing Aristolochic Acid: An Interrupted Time-Series Analysis

  • Jing-Rong Jhuang
  • , Chun-Ju Chiang
  •  & Wen-Chung Lee

• Article
  05 December 2019 | Open Access

  Proteasome inhibition disrupts the metabolism of fumarate hydratase- deficient tumors by downregulating p62 and c-Myc

  • Carole Sourbier
  • , Christopher J. Ricketts
  •  & W. Marston Linehan

• Article
  20 November 2019 | Open Access

  Characterization of the expression of LAT1 as a prognostic indicator and a therapeutic target in renal cell carcinoma

  • Kosuke Higuchi
  • , Shinichi Sakamoto
  •  & Naohiko Anzai

• Article
  13 November 2019 | Open Access

  Integrating multi-platform genomic datasets for kidney renal clear cell carcinoma subtyping using stacked denoising autoencoders

  • Tongjun Gu
  •  & Xiwu Zhao

• Article
  30 October 2019 | Open Access

  LC-MS based metabolomic profiling for renal cell carcinoma histologic subtypes

  • Lun Jing
  • , Jean-Marie Guigonis
  •  & Damien Ambrosetti

• Article
  29 October 2019 | Open Access

  Effect of third- and fourth-line systemic therapies for metastatic renal cell carcinoma

  • Sei Naito
  • , Osamu Ichiyanagi
  •  & Norihiko Tsuchiya

• Article
  03 June 2019 | Open Access

  Reduction in H3K4me patterns due to aberrant expression of methyltransferases and demethylases in renal cell carcinoma: prognostic and therapeutic implications

  • Aman Kumar
  • , Niti Kumari
  •  & Rajendra Prasad

• Article
  23 May 2019 | Open Access

  Metastatic Tumor Burden and Loci as Predictors of First Line Sunitinib Treatment Efficacy in Patients with Renal Cell Carcinoma

  • Anna M. Czarnecka
  • , Anna Brodziak
  •  & Cezary Szczylik

• Article
  20 March 2019 | Open Access

  Noninvasive Contrast-Free 3D Evaluation of Tumor Angiogenesis with Ultrasensitive Ultrasound Microvessel Imaging

  • Chengwu Huang
  • , Matthew R. Lowerison
  •  & Shigao Chen

• Article
  14 March 2019 | Open Access

  Simvastatin reduces the carcinogenic effect of 3-methylcholanthrene in renal epithelial cells through histone deacetylase 1 inhibition and RhoA reactivation

  • Chih-Cheng Chang
  • , Kuo-How Huang
  •  & Shu-Hui Juan

• Article
  01 March 2019 | Open Access

  The uremic toxin p-cresyl sulfate induces proliferation and migration of clear cell renal cell carcinoma via microRNA-21/ HIF-1α axis signals

  • Tsai-Kun Wu
  • , Chyou-Wei Wei
  •  & Yung-Luen Yu

• Article
  27 February 2019 | Open Access

  Linking Binary Gene Relationships to Drivers of Renal Cell Carcinoma Reveals Convergent Function in Alternate Tumor Progression Paths

  • William L. Poehlman
  • , James J. Hsieh
  •  & F. Alex Feltus

• Article
  21 February 2019 | Open Access

  The impact of estimated tumour purity on gene expression-based drug repositioning of Clear Cell Renal Cell Carcinoma samples

  • Karel K. M. Koudijs
  • , Anton G. T. Terwisscha van Scheltinga
  •  & Henk-Jan Guchelaar

• Article
  11 February 2019 | Open Access

  Piwi-like 1 protein expression is a prognostic factor for renal cell carcinoma patients

  • Christine G. Stöhr
  • , Sandra Steffens
  •  & Helge Taubert

• Article
  04 December 2018 | Open Access

  Dynamic prognostic model for kidney renal clear cell carcinoma (KIRC) patients by combining clinical and genetic information

  • Huiling Zhao
  • , Yuting Cao
  •  & Fangrong Yan

• Article
  17 September 2018 | Open Access

  Accurate Risk Assessment of Patients with Pathologic T3aN0M0 Renal Cell Carcinoma

  • Jong Jin Oh
  • , Jung Keun Lee
  •  & Sung Kyu Hong

• Article
  13 August 2018 | Open Access

  Endogenous HIF2A reporter systems for high-throughput functional screening

  • M. Nazhif Zaini
  • , Saroor A. Patel
  •  & Sakari Vanharanta

• Article
  06 August 2018 | Open Access

  Co-expression of Cancer Stem Cell Markers OCT4 and NANOG Predicts Poor Prognosis in Renal Cell Carcinomas

  • Arezoo Rasti
  • , Mitra Mehrazma
  •  & Mojgan Asgari

• Article
  02 July 2018 | Open Access

  Autophagy defects and related genetic variations in renal cell carcinoma with eosinophilic cytoplasmic inclusions

  • Zhou Yu
  • , Jing Ma
  •  & Zhe Wang

• Article
  26 April 2018 | Open Access

  The Correlation Between the Immune and Epithelial-Mesenchymal Transition Signatures Suggests Potential Therapeutic Targets and Prognosis Prediction Approaches in Kidney Cancer

  • Jiayu Liang
  • , Zhihong Liu
  •  & Yiping Lu